What is the appropriate dose of Bromfed (brompheniramine and pseudoephedrine) for a child weighing 32.26 kg?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 5, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Bromfed Dosing for 32.26 kg Child

For a child weighing 32.26 kg, administer 5 mL (1 teaspoonful) of Bromfed DM Cough Syrup every 4-6 hours, not to exceed 4 doses in 24 hours.

Dosing Rationale

The FDA-approved formulation contains per 5 mL: brompheniramine maleate 2 mg, pseudoephedrine hydrochloride 30 mg, and dextromethorphan hydrobromide 10 mg 1. At 32.26 kg, this child falls well within the weight range where standard pediatric dosing applies.

Weight-Based Considerations

  • This child is above the 30 kg threshold where weight-based dosing transitions toward adult dosing regimens 2
  • For children ≥40 kg, adult dosing should be used unless contraindicated 3
  • At 32.26 kg, this patient sits in the intermediate zone where standard pediatric dosing (5 mL) is appropriate

Component-Specific Dosing Analysis

Brompheniramine (2 mg per dose):

  • Guideline recommendations support 1-2 mg twice daily for children ≥2 years 4
  • This dose provides effective H1-receptor blockade with peak plasma concentrations at 3.2 hours and terminal half-life of 12.4 hours in children 5
  • The 2 mg dose produces significant wheal and flare suppression lasting 30 hours 5

Pseudoephedrine (30 mg per dose):

  • The terminal elimination half-life in children (3.1 hours) is significantly shorter than in adults, necessitating more frequent dosing 6
  • This dose provides effective nasal decongestion with onset within 30 minutes and peak activity at 1 hour 1

Critical Safety Warnings

Age-Related Precautions

  • Oral decongestants are well-tolerated in children >6 years but carry significant risks in younger children 4
  • Use below age 6 has been associated with agitated psychosis, ataxia, hallucinations, and death 4
  • Even at recommended doses, stimulatory effects including tachyarrhythmias, insomnia, and hyperactivity may occur 4

Contraindications and Monitoring

  • Avoid concurrent use with stimulant medications (e.g., ADHD medications) or caffeine due to increased adverse events 4
  • Monitor blood pressure, especially if hypertension is present 4
  • Use with extreme caution in cardiovascular disease, hyperthyroidism, closed-angle glaucoma, or bladder neck obstruction 4

Overdose Risk

The toxic dose of brompheniramine in a 2.5-year-old child was 300-900 mg (survived), while pseudoephedrine toxicity is estimated at <50 mg/kg 1. At 32.26 kg, this would be <1,613 mg pseudoephedrine—far exceeding therapeutic doses, but emphasizing the importance of strict dosing adherence.

Dosing Schedule

  • Frequency: Every 4-6 hours as needed
  • Maximum: 4 doses (20 mL total) in 24 hours
  • Duration: Brompheniramine provides 24-hour peripheral H1-blockade from a single dose, suggesting twice-daily dosing may be sufficient 5

Common Pitfalls to Avoid

  • Do not use weight-based mg/kg calculations for combination OTC products—follow labeled dosing 1
  • Do not exceed maximum daily doses to avoid CNS stimulation, anticholinergic effects, and cardiovascular complications 1
  • Verify the specific Bromfed formulation as different products exist with varying concentrations
  • Assess for concurrent medications that may interact, particularly other sympathomimetics or anticholinergics

411156

References

Research

Calculation of drug dosage and body surface area of children.

British journal of anaesthesia, 1997

Research

Medication Dosing for Children With Overweight and Obesity.

The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG, 2024

Guideline

the diagnosis and management of rhinitis: an updated practice parameter.

Journal of Allergy and Clinical Immunology, 2008

Research

The clinical pharmacology of brompheniramine in children.

The Journal of allergy and clinical immunology, 1999

Related Questions

What is the appropriate Bromfed (brompheniramine/pseudoephedrine) dose for a 47‑lb (≈21‑kg) child?
What dose of Bromfed DM (brompheniramine, pseudoephedrine, dextromethorphan) syrup is appropriate for a child weighing 60 lb (≈27 kg)?
What is the appropriate dose of Bromfed (brompheniramine/pseudoephedrine) for a 9‑year‑old child?
What is the recommended dose of Bromfed DM (brompheniramine/pseudoephedrine/dextromethorphan) syrup for adults and children?
What is the appropriate dose of Bromfed (brompheniramine, pseudoephedrine, guaifenesin) for a 30‑pound child?
What is the appropriate evaluation and management for a patient with severe lower extremity pain and painful bruising following a recent respiratory infection?
What is the most likely primary diagnosis and appropriate treatment plan for a 29-year-old male with chronic major depressive disorder, anxious distress, a brief stress-related psychotic episode, trauma-related anxiety, recent marital separation, and functional impairment?
In an adult with a history of non‑Hodgkin lymphoma who has had three episodes of generalized urticaria over the past three months, each resolving with systemic steroids and currently asymptomatic, what is the appropriate workup and management?
Can a patient with irritable bowel syndrome be prescribed glucagon-like peptide-1 (GLP-1) receptor agonists?
For a patient with a hypermobile atrial septum (atrial septal aneurysm) and a prominent eustachian valve who needs cardiac clearance for planned left knee surgery, what is the recommended peri‑operative management?
Which of these drugs—venlafaxine (Effexor), buspirone, prazosin, alprazolam—are safe to use during pregnancy?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.